501 related articles for article (PubMed ID: 9168186)
1. Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
Hudson MA; McReynolds LM
J Natl Cancer Inst; 1997 May; 89(10):709-17. PubMed ID: 9168186
[TBL] [Abstract][Full Text] [Related]
2. Urokinase (u-PA) and the u-PA receptor. Modulation of in vitro invasiveness of human bladder cancer cell lines.
Hudson MA; McReynold LM
Adv Exp Med Biol; 1999; 462():399-412. PubMed ID: 10599442
[TBL] [Abstract][Full Text] [Related]
3. Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness.
Holst-Hansen C; Johannessen B; Høyer-Hansen G; Rømer J; Ellis V; Brünner N
Clin Exp Metastasis; 1996 May; 14(3):297-307. PubMed ID: 8674284
[TBL] [Abstract][Full Text] [Related]
4. Urokinase-type plasminogen activator and its receptor in bladder cancer.
Hasui Y; Osada Y
J Natl Cancer Inst; 1997 May; 89(10):678-9. PubMed ID: 9168177
[No Abstract] [Full Text] [Related]
5. Re: urokinase and urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
Hasui Y; Osada Y
J Natl Cancer Inst; 1997 Nov; 89(21):1630-1. PubMed ID: 9362166
[No Abstract] [Full Text] [Related]
6. Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells.
Liu G; Shuman MA; Cohen RL
Int J Cancer; 1995 Feb; 60(4):501-6. PubMed ID: 7829264
[TBL] [Abstract][Full Text] [Related]
7. Re: urokinase and urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
Duffy MJ; Duggan C
J Natl Cancer Inst; 1997 Nov; 89(21):1628-30. PubMed ID: 9362165
[No Abstract] [Full Text] [Related]
8. Macrophage colony-stimulating factor mediates invasion of ovarian cancer cells through urokinase.
Chambers SK; Wang Y; Gertz RE; Kacinski BM
Cancer Res; 1995 Apr; 55(7):1578-85. PubMed ID: 7882368
[TBL] [Abstract][Full Text] [Related]
9. The expression of urokinase-related genes in superficial and invasive transitional cell carcinoma.
McGarvey TW; Kariko K; Barnathan ES; Thomas J; Malkowicz SB
Int J Oncol; 1998 Jan; 12(1):175-80. PubMed ID: 9454902
[TBL] [Abstract][Full Text] [Related]
10. Human bladder cancer invasion model using rat bladder in vitro and its use to test mechanisms and therapeutic inhibitors of invasion.
Fujiyama C; Jones A; Fuggle S; Bicknell R; Cranston D; Harris AL
Br J Cancer; 2001 Feb; 84(4):558-64. PubMed ID: 11207054
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen- and colony-stimulating factor-1-associated markers in bladder carcinoma: diagnostic value of urokinase plasminogen activator receptor and plasminogen activator inhibitor type-2 using immunocytochemical analysis.
Champelovier P; Boucard N; Levacher G; Simon A; Seigneurin D; Praloran V
Urol Res; 2002 Oct; 30(5):301-9. PubMed ID: 12389118
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the invasion capacity of carcinoma cells by WX-UK1, a novel synthetic inhibitor of the urokinase-type plasminogen activator system.
Ertongur S; Lang S; Mack B; Wosikowski K; Muehlenweg B; Gires O
Int J Cancer; 2004 Jul; 110(6):815-24. PubMed ID: 15170662
[TBL] [Abstract][Full Text] [Related]
13. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M
Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
[TBL] [Abstract][Full Text] [Related]
14. Tumour cell thrombospondin-1 regulates tumour cell adhesion and invasion through the urokinase plasminogen activator receptor.
Albo D; Rothman VL; Roberts DD; Tuszynski GP
Br J Cancer; 2000 Aug; 83(3):298-306. PubMed ID: 10917542
[TBL] [Abstract][Full Text] [Related]
15. High level of urokinase plasminogen activator contributes to cholangiocarcinoma invasion and metastasis.
Thummarati P; Wijitburaphat S; Prasopthum A; Menakongka A; Sripa B; Tohtong R; Suthiphongchai T
World J Gastroenterol; 2012 Jan; 18(3):244-50. PubMed ID: 22294827
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid-enhanced invasion through reconstituted basement membrane by human SK-N-SH neuroblastoma cells involves membrane-associated tissue-type plasminogen activator.
Tiberio A; Farina AR; Tacconelli A; Cappabianca L; Gulino A; Mackay AR
Int J Cancer; 1997 Nov; 73(5):740-8. PubMed ID: 9398056
[TBL] [Abstract][Full Text] [Related]
17. Re: Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
See WA
J Natl Cancer Inst; 1998 Sep; 90(17):1303. PubMed ID: 9731738
[No Abstract] [Full Text] [Related]
18. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
Festuccia C; Angelucci A; Gravina GL; Biordi L; Millimaggi D; Muzi P; Vicentini C; Bologna M
Thromb Haemost; 2005 May; 93(5):964-75. PubMed ID: 15886816
[TBL] [Abstract][Full Text] [Related]
19. Invasion of extracellular matrix by cultured colon cancer cells: dependence on urokinase receptor display.
Schlechte W; Brattain M; Boyd D
Cancer Commun; 1990; 2(5):173-9. PubMed ID: 2164413
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activators augment endothelial cell organization in vitro by two distinct pathways.
Schnaper HW; Barnathan ES; Mazar A; Maheshwari S; Ellis S; Cortez SL; Baricos WH; Kleinman HK
J Cell Physiol; 1995 Oct; 165(1):107-18. PubMed ID: 7559792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]